Is Ibogaine Legal in California? (2026)

Instrument

Schedule I: hallucinogenic substances

Source

https://leginfo.legislature.ca.gov/faces/codes_displaySection.xhtml?lawCode=HSC&sectionNum=11054

Retrieved

2026-10-31

Fingerprint

b88c6bdfa72ff45c

(a)The controlled substances listed in this section are included in Schedule I.
(d)Hallucinogenic substances. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation, which contains any quantity of the following hallucinogenic substances, or which contains any of its salts, isomers, and salts of isomers whenever the existence of those salts, isomers, and salts of isomers is possible within the specific chemical designation (for purposes of this subdivision only, the term "isomer" includes the optical, position, and geometric isomers):
(1)4-bromo-2,5-dimethoxy-amphetamine—Some trade or other names: 4-bromo-2,5-dimethoxy-alpha-methylphenethylamine; 4-bromo-2,5-DMA.
(2)2,5-dimethoxyamphetamine—Some trade or other names: 2,5-dimethoxy-alpha-methylphenethylamine; 2,5-DMA.
(3)4-methoxyamphetamine—Some trade or other names: 4-methoxy-alpha-methylphenethylamine, paramethoxyamphetamine, PMA.
(4)5-methoxy-3,4-methylenedioxy-amphetamine.
(5)4-methyl-2,5-dimethoxy-amphetamine—Some trade or other names: 4-methyl-2,5-dimethoxy-alpha-methylphenethylamine; “DOM”; and “STP.”
(6)3,4-methylenedioxy amphetamine.
(7)3,4,5-trimethoxy amphetamine.
(8)Bufotenine—Some trade or other names: 3-(beta-dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)-5 indolol; N,N-dimethylserolonin, 5-hydroxy-N,N-dimethyltryptamine; mappine.
(9)Diethyltryptamine—Some trade or other names: N,N-Diethyltryptamine; DET.
(10)Dimethyltryptamine—Some trade or other names: DMT.
(11)Ibogaine—Some trade or other names: 7-Ethyl-6,6beta, 7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-5H-pyrido [1’,2’:1,2] azepino [5,4-b] indole; Tabernantheiboga.
(12)Lysergic acid diethylamide.
(13)Cannabis.
(14)Mescaline.
(15)Peyote—Meaning all parts of the plant presently classified botanically as Lophophora williamsii Lemaire, whether growing or not, the seeds thereof, any extract from any part of the plant, and every compound, manufacture, salts, derivative, mixture, or preparation of the plant, its seeds or extracts (interprets 21 U.S.C. Sec. 812(c), Schedule 1(c)(12)).
(16)N-ethyl-3-piperidyl benzilate.
(17)N-methyl-3-piperidyl benzilate.
(18)Psilocybin.
(19)Psilocyn.
(20)Tetrahydrocannabinols. Synthetic equivalents of the substances contained in the plant, or in the resinous extractives of Cannabis, sp. and/or synthetic substances, derivatives, and their isomers with similar chemical structure and pharmacological activity such as the following: delta 1 cis or trans tetrahydrocannabinol, and their optical isomers; delta 6 cis or trans tetrahydrocannabinol, and their optical isomers; delta 3,4 cis or trans tetrahydrocannabinol, and its optical isomers.
Because nomenclature of these substances is not internationally standardized, compounds of these structures, regardless of numerical designation of atomic positions covered.
(21)Ethylamine analog of phencyclidine—Some trade or other names: N-ethyl-1-phenylcyclohexylamine, (1-phenylcyclohexyl) ethylamine, N-(1-phenylcyclohexyl) ethylamine, cyclohexamine, PCE.
(22)Pyrrolidine analog of phencyclidine—Some trade or other names: 1-(1-phenylcyclohexyl)-pyrrolidine, PCP, PHP.
(23)Thiophene analog of phencyclidine—Some trade or other names: 1-[1-(2 thienyl)-cyclohexyl]-piperidine, 2-thienyl analog of phencyclidine, TPCP, TCP.

Instrument

Schedule I, hallucinogenic substances

Source

https://www.pharmacy.ca.gov/laws_regs/lawbook.pdf

Retrieved

2026-10-28

Fingerprint

aee2bbff7cb9c901

(d) Hallucinogenic substances. Unless specifically excepted or
unless listed in another schedule, any material, compound,
mixture, or preparation, which contains any quantity of the
following hallucinogenic substances, or which contains any of its
salts, isomers, and salts of isomers whenever the existence of
those salts, isomers, and salts of isomers is possible within the
specific chemical designation (for purposes of this subdivision
only, the term "isomer" includes the optical, position, and
geometric isomers):
  (1) 4-bromo-2,5-dimethoxy-amphetamine--Some trade or other
names: 4-bromo-2,5-dimethoxy-alphamethylphenethylamine;
4-bromo-2,5-DMA.
  (2) 2,5-dimethoxyamphetamine--Some trade or other names:
2,5-dimethoxy-alpha-methylphenethylamine; 2,5-DMA.
  (3) 4-methoxyamphetamine--Some trade or other names: 4-
methoxy-alpha-methylphenethylamine,
paramethoxyamphetamine, PMA.
  (4) 5-methoxy-3,4-methylenedioxy-amphetamine.
  (5) 4-methyl-2,5-dimethoxy-amphetamine--Some trade or other
names: 4-methyl-2,5-dimethoxy-alphamethylphenethylamine;
“DOM”; and “STP.”

636

Rev 7/2026

  (6) 3,4-methylenedioxy amphetamine.
  (7) 3,4,5-trimethoxy amphetamine.
  (8) Bufotenine--Some trade or other names: 3-(beta-
dimethylaminoethyl)-5-hydroxyindole; 3-(2-
dimethylaminoethyl)-5indolol; N,N-dimethylserolonin, 5-hydroxy-
N,N-dimethyltryptamine; mappine.
  (9) Diethyltryptamine--Some trade or other names:N,N-
Diethyltryptamine; DET.
  (10) Dimethyltryptamine--Some trade or other names: DMT.
  (11) Ibogaine--Some trade or other names: 7-Ethyl-6,6beta,
7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-5Hpyrido
(1',2':1,2) azepino (5,4-b) indole; Tabernantheiboga.
  (12) Lysergic acid diethylamide.
  (13) Cannabis.
  (14) Mescaline.
  (15) Peyote—Meaning all parts of the plant presently classified
botanically as Lophophora williamsii Lemaire, whether growing
or not, the seeds thereof, any extract from any part of the plant,
and every compound, manufacture, salts, derivative, mixture, or
preparation of the plant, its seeds or extracts (interprets 21
U.S.C. Sec. 812(c), Schedule 1(c)(12)).
  (16) N-ethyl-3-piperidyl benzilate.
  (17) N-methyl-3-piperidyl benzilate.
  (18) Psilocybin.
  (19) Psilocyn.
  (20) Tetrahydrocannabinols. Synthetic equivalents of the
substances contained in the plant, or in the resinous extractives
of Cannabis, sp. and/or synthetic substances, derivatives, and
their isomers with similar chemical structure and
pharmacological activity such as the following: delta 1 cis or trans
tetrahydrocannabinol, and their optical isomers; delta 6 cis or
trans tetrahydrocannabinol, and their optical isomers; delta 3,4
cis or trans tetrahydrocannabinol, and its optical isomers.
Because nomenclature of these substances is not internationally
standardized, compounds of these structures, regardless of
numerical designation of atomic positions covered.

637

Rev 7/2026

  (21) Ethylamine analog of phencyclidine--Some trade or other
names: N-ethyl-1-phenylcyclohexylamine, (1-phenylcyclohexyl)
ethylamine, N-(1-phenylcyclohexyl) ethylamine, cyclohexamine,
PCE.
  (22) Pyrrolidine analog of phencyclidine--Some trade or other
names: 1-(1-phenylcyclohexyl)-pyrrolidine, PCP, PHP.
  (23) Thiophene analog of phencyclidine--Some trade or other
names: 1-(1-(2 thienyl)-cyclohexyl)-piperidine, 2- thienyl analog
of phencyclidine, TPCP, TCP.

Instrument

Schedule III: subdivisions (a) through (g), ending with (g) ketamine

Source

https://www.pharmacy.ca.gov/laws_regs/lawbook.pdf

Retrieved

2026-10-31

Fingerprint

c3f4f9f89e4bf519

(a)The controlled substances listed in this section are included in Schedule III.
(b)Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers (whether optical, position, or geometric), and salts of those isomers whenever the existence of those salts, isomers, and salts of isomers is possible within the specific chemical designation:
(1)Those compounds, mixtures, or preparations in dosage unit form containing any stimulant substances listed in Schedule II which compounds, mixtures, or preparations were listed on August 25, 1971, as excepted compounds under Section 1308.32 of Title 21 of the Code of Federal Regulations, and any other drug of the quantitative composition shown in that list for those drugs or that is the same except that it contains a lesser quantity of controlled substances.
(2)Benzphetamine.
(3)Chlorphentermine.
(4)Clortermine.
(5)Mazindol.
(6)Phendimetrazine.
(c)Depressants. Unless specifically excepted in Section 11059 or elsewhere, or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances having a depressant effect on the central nervous system:
(1)Any compound, mixture, or preparation containing any of the following:
(A)Amobarbital.
(B)Secobarbital.
(C)Pentobarbital or any salt thereof and one or more other active medicinal ingredients that are not listed in any schedule.
(2)Any suppository dosage form containing any of the following:
(A)Amobarbital.
(B)Secobarbital.
(C)Pentobarbital or any salt of any of these drugs and approved by the federal Food and Drug Administration for marketing only as a suppository.
(3)Any substance that contains any quantity of a derivative of barbituric acid or any salt thereof.
(4)Chlorhexadol.
(5)Lysergic acid.
(6)Lysergic acid amide.
(7)Methyprylon.
(8)Sulfondiethylmethane.
(9)Sulfonethylmethane.
(10)Sulfonmethane.
(11)Gamma hydroxybutyric acid, and its salts, isomers, and salts of isomers, contained in a drug product for which an application has been approved under Section 505 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. Sec. 355).
(d)Nalorphine.
(e)Narcotic drugs. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below:
(1)Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium.
(2)Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts.
(3)Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active nonnarcotic ingredients in recognized therapeutic amounts.
(4)Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts.
(5)Not more than 500 milligrams of opium per 100 milliliters or per 100 grams or not more than 25 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts.
(6)Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts.
(f)Anabolic steroids and chorionic gonadotropin, except for human chorionic gonadotropin (hCG). Any material, compound, mixture, or preparation containing chorionic gonadotropin, except hCG, or an anabolic steroid (excluding anabolic steroid products listed in the “Table of Exempt Anabolic Steroid Products” (Section 1308.34 of Title 21 of the Code of Federal Regulations), as exempt from the federal Controlled Substances Act (Section 801 and following of Title 21 of the United States Code)), including, but not limited to, the following:
(1)Androisoxazole.
(2)Androstenediol.
(3)Bolandiol.
(4)Bolasterone.
(5)Boldenone.
(6)Chloromethandienone.
(7)Clostebol.
(8)Dihydromesterone.
(9)Ethylestrenol.
(10)Fluoxymesterone.
(11)Formyldienolone.
(12)4-Hydroxy-19-nortestosterone.
(13)Mesterolone.
(14)Methandriol.
(15)Methandrostenolone.
(16)Methenolone.
(17)17-Methyltestosterone.
(18)Methyltrienolone.
(19)Nandrolone.
(20)Norbolethone.
(21)Norethandrolone.
(22)Normethandrolone.
(23)Oxandrolone.
(24)Oxymesterone.
(25)Oxymetholone.
(26)Quinbolone.
(27)Stanolone.
(28)Stanozolol.
(29)Stenbolone.
(30)Testosterone.
(31)Trenbolone.
(g)Ketamine. Any material, compound, mixture, or preparation containing ketamine.

Instrument

Controlled substance analogs

Source

https://leginfo.legislature.ca.gov/faces/codes_displaySection.xhtml?lawCode=HSC&sectionNum=11401

Retrieved

2026-11-01

Fingerprint

abcff0d3f9ecfe9d

11401.  

(a) A controlled substance analog shall, for the purposes of Chapter 6 (commencing with Section 11350), be treated the same as the controlled substance classified in Section 11054 or 11055 or the synthetic cannabinoid compound defined in Section 11357.5 of which it is an analog.

(b) Except as provided in subdivision (c), the term “controlled substance analog” means either of the following:

(1) A substance the chemical structure of which is substantially similar to the chemical structure of a controlled substance classified in Section 11054 or 11055 or a synthetic cannabinoid compound defined in Section 11357.5.

(2) A substance that has, is represented as having, or is intended to have a stimulant, depressant, or hallucinogenic effect on the central nervous system that is substantially similar to, or greater than, the stimulant, depressant, or hallucinogenic effect on the central nervous system of a controlled substance classified in Section 11054 or 11055 or a synthetic cannabinoid compound defined in Section 11357.5.

(c) The term “controlled substance analog” does not mean any of the following:

(1) A substance for which there is an approved new drug application as defined under Section 505 of the federal Food, Drug, and Cosmetic Act (21 U.S.C. Sec. 355) or that is generally recognized as safe and effective for use pursuant to Sections 501, 502, and 503 of the federal Food, Drug, and Cosmetic Act (21 U.S.C. Secs. 351, 352, and 353) and Section 330 and following of Title 21 of the Code of Federal Regulations.

(2) With respect to a particular person, a substance for which an exemption is in effect for investigational use for that person under Section 505 of the federal Food, Drug, and Cosmetic Act (21 U.S.C. Sec. 355), to the extent that the conduct with respect to that substance is pursuant to the exemption.

(3) A substance, before an exemption as specified in paragraph (2) takes effect with respect to the substance, to the extent the substance is not intended for human consumption.

Instrument

Nitrous oxide: possession for intoxication, sale to minors, dispensing, recordkeeping (law in force)

Source

https://leginfo.legislature.ca.gov/faces/codes_displaySection.xhtml?lawCode=PEN&sectionNum=381c.

Retrieved

2026-10-31

Fingerprint

596c81f023dc4afa

381b.

Any person who possesses nitrous oxide or any substance containing nitrous oxide, with the intent to breathe, inhale, or ingest for the purpose of causing a condition of intoxication, elation, euphoria, dizziness, stupefaction, or dulling of the senses or for the purpose of, in any manner, changing, distorting, or disturbing the audio, visual, or mental processes, or who knowingly and with the intent to do so is under the influence of nitrous oxide or any material containing nitrous oxide is guilty of a misdemeanor. This section shall not apply to any person who is under the influence of nitrous oxide or any material containing nitrous oxide pursuant to an administration for the purpose of medical, surgical, or dental care by a person duly licensed to administer such an agent.

381c.

(a)
As used in this section, "nitrous oxide" refers to any of the following substances: N2O, dinitrogen monoxide, dinitrogen oxide, nitrogen oxide, or laughing gas.
(b)
Every person who sells, furnishes, administers, distributes, gives away, or offers to sell, furnish, administer, distribute, or give away a device, canister, tank, or receptacle either exclusively containing nitrous oxide or exclusively containing a chemical compound mixed with nitrous oxide, to a person under 18 years of age is guilty of a misdemeanor. The court shall consider ordering the person to perform community service as a condition of probation.
(c)
(1)
It is a defense to this crime that the defendant honestly and reasonably believed that the minor involved in the offense was at least 18 years of age.
(2)
The defendant shall bear the burden of establishing this defense by a preponderance of the evidence.
(d)
For the purpose of preventing a violation of this section, any person may refuse to sell, furnish, administer, distribute, or give away a device, canister, tank, or receptacle either exclusively containing nitrous oxide or exclusively containing a chemical compound mixed with nitrous oxide to a person who is unable to produce adequate proof of age of majority.
(e)
On and after July 1, 2010, the court shall order the suspension of the business license, for a period of up to one year, of a person who knowingly violates this section after having been previously convicted of a violation of this section, unless the owner of the business license can demonstrate a good faith attempt to prevent illegal sales or deliveries by the owner's employees.
(f)
This section shall not apply to any person who administers nitrous oxide for the purpose of providing medical or
				  dental care, if administered by a medical or dental practitioner licensed by this state or at the direction or under the supervision of a practitioner licensed by this state.
(g)
This section does not apply to the sale of nitrous oxide contained in food products for use as a propellant.

381d.

(a)
A person who dispenses or distributes nitrous oxide to a person, and knows or should know that the person is going to use the nitrous oxide in violation of Section 381b, and that person proximately causes great bodily injury or death to himself, herself, or another person, is guilty of a misdemeanor, and shall be punished by imprisonment in a county jail, not to exceed six months, or by a fine not to exceed one thousand dollars ($1,000), or by both that fine and imprisonment.
(b)
This section shall not preclude prosecution under any other law.

381e.

(a)
A person who dispenses or distributes nitrous oxide shall record each transaction involving the dispensing or distribution of nitrous oxide in a written or electronic document. The person dispensing or distributing the nitrous oxide shall require the purchaser to sign the document and provide a complete residential address and present a valid government-issued photo identification. The person dispensing or distributing the nitrous oxide shall sign and date the document and shall retain the document at the person’s business address for one year from the date of the transaction. The person shall make the documents available during normal business hours for inspection and copying,
						upon presentation of a duly authorized search warrant, by officers or employees of the California State Board of Pharmacy or of other law enforcement agencies of this state or the United States.
(b)
The document used to record each transaction shall inform the purchaser of all of the following:
(1)
That inhalation of nitrous oxide outside of a clinical setting may have dangerous health effects.
(2)
That it is a violation of state law to possess nitrous oxide or any substance containing nitrous oxide, with the intent to breathe, inhale, or ingest it for the purpose of intoxication.
(3)
That it is a violation of state law to knowingly distribute or dispense
						nitrous oxide or any substance containing nitrous oxide, to a person who intends to breathe, inhale, or ingest it for the purpose of intoxication.
(c)
This section shall not apply to any person who administers nitrous oxide for the purpose of providing medical or dental care, if administered by a medical or dental practitioner licensed by this state or at the direction or under the supervision of a practitioner licensed by this state.
(d)
This section does not apply to the sale of nitrous oxide contained in food products for use as a propellant.
(e)
This section shall not apply to the sale or distribution of nitrous oxide by a wholesaler licensed by the Board of Pharmacy or manufacturer classified under Code Number
						325120 or 424690 of the North American Industry Classification System (NAICS).
(f)
(1)
Information obtained from a person to whom nitrous oxide was distributed or dispensed pursuant to this section shall be confidential and shall be used solely for the purposes provided in this section.
(2)
 Except as provided in this section, a person who dispenses or distributes nitrous oxide shall not use, review, or disclose any information obtained pursuant to this section.
(3)
A person who violates this
						subdivision shall be guilty of a misdemeanor, punishable by imprisonment in a county jail not to exceed six months, or by a fine not to exceed one thousand dollars ($1,000), or by both that fine and imprisonment.

Instrument

Salvia divinorum or salvinorin A: furnishing to persons under 18

Source

https://leginfo.legislature.ca.gov/faces/codes_displaySection.xhtml?lawCode=PEN&sectionNum=379

Retrieved

2026-10-31

Fingerprint

c584d1af7b0a0c8d

Every person who sells, dispenses, distributes, furnishes, administers, gives, or offers to sell, dispense, distribute, furnish, administer, or give Salvia divinorum or Salvinorin A, or any substance or material containing Salvia divinorum or Salvinorin A, to any person who is less than 18 years of age, is guilty of a misdemeanor punishable by imprisonment in a county jail not exceeding six months, or by a fine not exceeding one thousand dollars ($1,000), or by both that fine and imprisonment.